Ditchcarbon
  • Contact
  1. Organizations
  2. Freenome Holdings, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Freenome Holdings, Inc.

Company website

Freenome Holdings, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in the development of advanced multi-omics technology for early cancer detection. Freenome's innovative approach combines artificial intelligence with blood-based biomarker analysis, offering unique insights that enhance diagnostic accuracy. With a focus on colorectal cancer screening, Freenome's flagship product stands out for its ability to detect cancer at its earliest stages, significantly improving patient outcomes. The company has achieved notable milestones, including partnerships with leading healthcare institutions and recognition for its contributions to cancer diagnostics. As a key player in the oncology landscape, Freenome continues to drive advancements that redefine cancer detection and management.

DitchCarbon Score

How does Freenome Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Freenome Holdings, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.

29%

Let us know if this data was useful to you

Freenome Holdings, Inc.'s reported carbon emissions

Freenome Holdings, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Freenome may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for Freenome to establish clear climate commitments and reduction initiatives to align with global standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Freenome Holdings, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Freenome Holdings, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Freenome Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Guardant Health

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Foundation Medicine, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Caris Life Sciences

US
•
Health and social work services (85)
Updated 4 days ago

Inivata Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Labcorp Drug Development Inc.

US
•
Research and development services (73)
Updated about 1 month ago

Adaptive Biotechnologies

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251024.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy